Skip to main content

Market Overview

38 Stocks Moving In Tuesday's Mid-Day Session



  • Precipio Inc (NASDAQ: PRPO) shares surged 42.7 percent to $0.35 following news the company is in talks with a manufacturer to produce its IV-cell media.
  • Command Center, Inc. (NASDAQ: CCNI) shares climbed 37.2 percent to $5.38 following news the company will merger in an all-stock deal with Hire Quest.
  • Yuma Energy Inc (NYSE: YUMA) shares gained 35.2 percent to $0.23.
  • Provention Bio, Inc. (NASDAQ: PRVB) shares rose 22.5 percent to $3.10. Provention Bio initiated Phase 3 PROTECT clinical trial with PRV-031.
  • PhaseBio Pharmaceuticals Inc (NASDAQ: PHAS) gained 21 percent to $15.20 after the company received FDA breakthrough therapy designation for PB2452 for the reversal of antiplatelet activity of ticagrelor.
  • Chimerix, Inc. (NASDAQ: CMRX) shares jumped 21 percent to $2.5285. Chimerix announced the appointment of former Endocyte CEO Michael Sherman as its CEO, effective immediately. Additionally, the company announced the appointment of Michael Andriole, also a former Endocyte executive, to the newly created position of Chief Business Officer.
  • FARO Technologies, Inc. (NASDAQ: FARO) gained 20.4 percent to $56.75 after the company appointed Michael Burger as the company's President and CEO following the company's previous President and CEO announcing his retirement.
  • Soliton, Inc. (NASDAQ: SOLY) shares jumped 18.7 percent to $13.45 after the company said it has completed the first evaluation for timepoint to treat cellulite.
  • Camber Energy Inc (NYSE: CEI) gained 18 percent to $0.43.
  • CEL-SCI Corporation (NYSE: CVM) shares rose 14 percent to $7.01.
  • Viveve Medical Inc (NASDAQ: VIVE) gained 13.8 percent to $0.66.
  • Netshoes (Cayman) Limited (NYSE: NETS) climbed 10.5 percent to $2.31.
  • Cerner Corporation (NASDAQ: CERN) gained 9.9 percent to $62.74 after the company announced an agreement with Starboard Value. Cerner raised its operating margin targets and announced a new $1.2 billion buyback.
  • Puxin Limited (NYSE: NEW) shares rose 9.5 percent to $9.23.
  • Adomani Inc (NASDAQ: ADOM) gained 9.3 percent to $0.3660 following news company received initial orders from GerWeiss in Philippines. The order represents a sales opportunity of $1.7 million.
  • Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) climbed 9.2 percent to $2.3800.
  • Rosehill Resources Inc. (NASDAQ: ROSE) rose 8.3 percent to $3.5200.
  • ASV Holdings, Inc. (NASDAQ: ASV) gained 7.8 percent to $2.7060.
  • InflaRx N.V. (NASDAQ: IFRX) rose 7.2 percent to $43.65.
  • TMSR Holding Company Limited (NASDAQ: TMSR) rose 6.4 percent to $2.00.

Check out these big penny stock gainers and losers


  • Vaxart, Inc. (NASDAQ: VXRT) shares dropped 35.6 percent to $0.9599 after the company announced pricing of its public offering of common stock at $1.10 per share.
  • Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) fell 24.8 percent to $17.48 following news of a 7.8 million common stock offering. The stock was downgraded by JP Morgan.
  • Zosano Pharma Corporation (NASDAQ: ZSAN) declined 23.8 percent to $3.8200 after the company announced and priced a $17.5 million common stock offering.
  • Dare Bioscience Inc (NASDAQ: DARE) fell 23.4 percent to $1.0500 after the company priced 4.575 million shares at $1.10 per share.
  • Zogenix, Inc. (NASDAQ: ZGNX) fell 22.7 percent to $40.07 after the FDA sent a 'refusal to file letter' to the company for its new drug application for FINTEPLA. Guggenheim downgraded the stock from Buy to Neutral.
  • Outlook Therapeutics, Inc. (NASDAQ: OTLK) dropped 15 percent to $4.0631.
  • Pentair plc (NYSE: PNR) shares declined 14.7 percent to $38.60 after the company reported worse-than-expected Q1 EPS. The company also cut FY19 EPS guidance from $2.50-$2.60 to $2.30-$2.35, beneath the $2.56 estimate.
  • Niu Technologies (NASDAQ: NIU) fell 11.9 percent to $11.85 after climbing 28.12 percent on Monday.
  • Homology Medicines Inc (NASDAQ: FIXX) fell 11.6 percent to $26.13. Homology Medicines said it intends to offer $125 million worth of its common stock in an underwritten public offering.
  • Novartis AG (NYSE: NVS) fell 11.1 percent to $84.44 after the company spun off Alcon into an independent publicly traded company.
  • Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) shares declined 9.8 percent to $3.4650.
  • Key Energy Services, Inc. (NYSE: KEG) dropped 9.4 percent to $4.15.
  • United States Steel Corporation (NYSE: X) fell 7.8 percent to $18.21. Credit Suisse downgraded United States Steel from Neutral to Underperform and lowered the price target from $21 to $13.
  • AVROBIO, Inc. (NASDAQ: AVRO) dropped 7.6 percent to $25.23.
  • New Age Beverages Corporation (NASDAQ: NBEV) fell 7.4 percent to $6.14 after the stock rose 38 percent Monday following the announcement of an expanded distribution deal with Walmart.
  • Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) dropped 7.3 percent to $10.02.
  • Lindsay Corporation (NYSE: LNN) shares fell 7 percent to $87.50 after reporting downbeat Q2 results.
  • Arbutus Biopharma Corporation (NASDAQ: ABUS) shares declined 6.4 percent to $4.12.

Related Articles (ABUS + ADOM)

View Comments and Join the Discussion!

Posted-In: LosersNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at